ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.00%
US Tech 100
18,163.60
0.75%
S&P 500
5,277.51
0.00%
US Dollar vs CAD
1.36293
-0.17%
Bitcoin
69,357.13
2.37%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alpha Tau Medical Ltd (DRTSW)

  7. Alpha Tau Medical Ltd (DRTSW) News

DRTSW

Alpha Tau Medical (DRTSW)

Alpha Tau Medical Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DRTSW
DateTimeSourceHeadlineSymbolCompany
05/21/20247:47AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
05/21/20247:45AMGlobeNewswire Inc.Alpha Tau to Present at the Jefferies Global Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
05/20/20243:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
05/20/20243:01PMGlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
05/13/20243:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
05/13/20247:30AMGlobeNewswire Inc.Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
05/06/20247:32AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRTSWAlpha Tau Medical Ltd
05/06/20247:30AMGlobeNewswire Inc.Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowNASDAQ:DRTSWAlpha Tau Medical Ltd
05/01/20247:30AMGlobeNewswire Inc.Alpha Tau to Participate in May Investor ConferencesNASDAQ:DRTSWAlpha Tau Medical Ltd
03/25/20247:50AMGlobeNewswire Inc.Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitNASDAQ:DRTSWAlpha Tau Medical Ltd
03/07/20243:01PMGlobeNewswire Inc.Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
02/26/20247:30AMGlobeNewswire Inc.Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
12/20/20238:15AMGlobeNewswire Inc.Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
11/29/20237:30AMGlobeNewswire Inc.Alpha Tau to Participate in Sidoti Small-Cap ConferenceNASDAQ:DRTSWAlpha Tau Medical Ltd
11/28/20237:30AMGlobeNewswire Inc.Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
11/20/20237:30AMGlobeNewswire Inc.Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNASDAQ:DRTSWAlpha Tau Medical Ltd
11/16/20233:30PMGlobeNewswire Inc.Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
10/30/20237:30AMGlobeNewswire Inc.Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilityNASDAQ:DRTSWAlpha Tau Medical Ltd
10/24/20238:00AMGlobeNewswire Inc.Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory BoardNASDAQ:DRTSWAlpha Tau Medical Ltd
09/14/20237:30AMGlobeNewswire Inc.Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical CenterNASDAQ:DRTSWAlpha Tau Medical Ltd
08/28/20233:02PMGlobeNewswire Inc.Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
08/17/20234:00PMGlobeNewswire Inc.Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTNASDAQ:DRTSWAlpha Tau Medical Ltd
05/24/20233:01PMGlobeNewswire Inc.Alpha Tau Medical to Participate in June Investor ConferencesNASDAQ:DRTSWAlpha Tau Medical Ltd
05/23/20233:01PMGlobeNewswire Inc.Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:DRTSWAlpha Tau Medical Ltd
05/17/20233:30PMGlobeNewswire Inc.Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityNASDAQ:DRTSWAlpha Tau Medical Ltd
05/11/20233:00PMGlobeNewswire Inc.Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenNASDAQ:DRTSWAlpha Tau Medical Ltd
05/03/20233:00PMGlobeNewswire Inc.Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayNASDAQ:DRTSWAlpha Tau Medical Ltd
04/03/20238:10AMGlobeNewswire Inc.Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical TrialNASDAQ:DRTSWAlpha Tau Medical Ltd
03/29/20233:00PMGlobeNewswire Inc.Alpha Tau Medical to Present at Jefferies Radiopharma Innovation SummitNASDAQ:DRTSWAlpha Tau Medical Ltd
03/12/20237:30AMGlobeNewswire Inc.Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley BankNASDAQ:DRTSWAlpha Tau Medical Ltd
 Showing the most relevant articles for your search:NASDAQ:DRTSW

Your Recent History

LSE
OUT
NASDAQ
MPVD
Mountain Province Diamonds
NASDAQ
LNZAW
LanzaTech Global
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved